A Randomized, Double Blind, Phase 3 Study Of The Efficacy And Safety Of XXXXX In Subjects Requiring NSAID Treatment.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Determine Whether, In Patients With Type 2 Diabetes At High Risk For Cardiovascular And Renal Events, XXXXX, On Top Of Conventional Treatment, Reduces Cardiovascular And Renal Morbidity And Mortality.
A Multi-Center, Randomized, Double-Blind, Placebo And Active Controlled, Parallel Group, Dose Range Study To Evaluate The Efficacy And Safety Of XXXXX Comparatively To XXXXX, And To Evaluate XXXXX To Placebo After 8 Week Treatment In Patients With Essential Hypertension.
A Long-Term, Open Label Safety And Efficacy Study Of XXXXX In Subjects With Fibromyalgia.
A Randomized Evaluation Of Long Term Anticoagulation Therapy Comparing The Efficacy And Safety Of Two Blinded Doses Of XXXXX With Open Label Warfarin For The Prevention Of Stroke And Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation: Prospective, Multi-Centre, Parallel-Group, Non-Inferiority Trial.
